Rheumatology International

, Volume 28, Issue 5, pp 467–473 | Cite as

Serum leptin in systemic lupus erythematosus

  • M. Wisłowska
  • M. Rok
  • K. Stępień
  • A. Kuklo-Kowalska
Original Article


Leptin, a peptide hormone, plays an essential role in the regulation of body weight, the endocrine function, reproduction, the immune response and inflammation. The immune system, in turn, modifies leptin’s production. Systemic lupus erythematosus (SLE) is an autoimmunological disease characterized by widespread inflammation with possible involvement of each body organ and system. In this study, we assessed serum leptin levels in SLE patients and the control group in search for correlations between leptin concentrations and other markers’ level, the activity of the disease, its duration, the age of the patients and their bone mineral density. Blood samples were collected from 30 SLE and 30 control group women. Each SLE patient was matched with one from the control for age (±1 year) and the body mass index (BMI; ±1). Serum leptin levels were determined using the DRG Leptin ELISA Kit. Serum leptin levels in SLE patients ranged from 1.8 to 66.3 ng/ml (median value 7.5), and in control group it was 8.8 ng/ml (0.7–39.2) (NS). In SLE, serum leptin levels (after the logarithmic transformation) correlated with BMI (r = 0.89, P < 0.0001), the age (r = 0.34, P < 0.01) and the patients’ disease duration (r = 0.59, P < 0.0005). Serum leptin levels in SLE patients with arthritis (P < 0.05) and central nervous system (CNS) involvement (P = 0.05) were significantly lower in comparison with serum leptin levels in SLE patients without arthritis and CNS involvement. No correlation was found between serum leptin levels and the T-score. In the control group, the logarithmic transformation of serum leptin levels positively correlated with BMI (r = 0.52, P < 0.05). No differences in serum leptin levels were shown between SLE patients and the control group. However, we found correlation between BMI and serum leptin levels in both groups. Furthermore, serum leptin levels in SLE patients with arthritis and CNS involvement were significantly lower in comparison with SLE patients without arthritis and CNS involvement, which suggests that active chronic inflammation may lower plasma leptin concentrations.


BMI Leptin Systemic lupus erythematosus T-score 


  1. 1.
    Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413–437PubMedCrossRefGoogle Scholar
  2. 2.
    Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68:437–446PubMedGoogle Scholar
  3. 3.
    Lord GM, Matarese G, Howard JK et al (1998) Leptin modulates the T-cell immune response and reserves starvation-induced immunosuppression. Nature 394:897–901PubMedCrossRefGoogle Scholar
  4. 4.
    Busso N, So A, Chobaz-Peclat V et al (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 169:875–877Google Scholar
  5. 5.
    Howard JK, Lor GM, Matarese G et al (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob./ob. mice. J Clin Invest 104:1051–1059PubMedCrossRefGoogle Scholar
  6. 6.
    Farooqi IS, Matarese G, Lord GM et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093–1103PubMedCrossRefGoogle Scholar
  7. 7.
    Saraf P, Fantuzzi G, Fuler J (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185:171–175CrossRefGoogle Scholar
  8. 8.
    Faggioni R, Fantuzzi G, Fuler J et al (1998) Il-1 beta mediates leptin induction during inflammation. Am J Physiol 274:R204–R208PubMedGoogle Scholar
  9. 9.
    Loffreda S, Yang SQ, Lin HZ et al (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:577–585Google Scholar
  10. 10.
    Gabay C, Dreyer M, Pellegrineli N et al (2001) Leptin directly induces the secretion of interleulin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86:783–791PubMedCrossRefGoogle Scholar
  11. 11.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRefGoogle Scholar
  12. 12.
    Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRefGoogle Scholar
  13. 13.
    Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–634PubMedCrossRefGoogle Scholar
  14. 14.
    Gladman DD, Goldsmith CH, Urowitz MB et al (2000) The systemic lupus international collaborating clinics/American College of Rheumatology (SLICC/ARC) damage index for systemic lupus erythematosus international comparison. J Rheumatol 27:373–376PubMedGoogle Scholar
  15. 15.
    Emlen W, O’Neill LO (1997) Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. Arthritis Rheum 40:1612–1618PubMedCrossRefGoogle Scholar
  16. 16.
    Conside RV, Sinha MK, Heiman ML (1996) Serum immunoreactive-leptin concentrations in normal weight and obese humans. New Engl J Med 334:292–295CrossRefGoogle Scholar
  17. 17.
    Robert R, Sokal F, Rohlf J (1986) Biometry. Freeman, New York, pp 354–359, 691–714Google Scholar
  18. 18.
    Gainsford T, Wilson TA, Metcalf D et al (1996) Leptin can induce proliferation, differentiation and functional activation of hemopoeitic cells. Proc Natl Acad Sci USA 93:14564–14568PubMedCrossRefGoogle Scholar
  19. 19.
    Harle P, Pongratz G, Weidler C et al (2004) Possible role of lepton in hypoandrogenicity in patients with systemie lapus erythematosus and rheumatoid arthritis. Ann Rheum Dis 63:809–816PubMedCrossRefGoogle Scholar
  20. 20.
    Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC et al (2002) Serum lepton levels In women with systemie lapus erythematosus. Rheumatol Int 22:138–141PubMedCrossRefGoogle Scholar
  21. 21.
    Bokarewa M, Bokarew D, Hultgren O et al (2003) Leptin consumption in the inflammed joint of patients with rheumatoid arthritis. Ann Rheum Dis 62:952–956PubMedCrossRefGoogle Scholar
  22. 22.
    Tokarczuk-Knapik A, Nowicki M, Wyroslak J (2002) The relation between plasma lepton concentration and body FAT mass In patients with rheumatoid arthritis. Pol Arch Med Wewn 108:761–767Google Scholar
  23. 23.
    Anders HJ, Rihl M, Heufelder A et al (1999) Leptin serum levels are not correlated with disease activity In patients with rheumatoid arthritis. Metabolism 48:745–748PubMedCrossRefGoogle Scholar
  24. 24.
    Nishija K, Nishiiyama M, Chang A et al (2002) Serum lepton level In patients with rheumatoid arthritis are correlated with body mass index. Abstr Rinshobyori 50:524–527Google Scholar
  25. 25.
    Wislowska M, Rok M, Jaszczyk B et al (2007) Serum lepton in rheumatoid arthritis. Rheumatol Int 27:947–954PubMedCrossRefGoogle Scholar
  26. 26.
    Rubin CT, Lanyon LE (1985) Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37:411–417PubMedCrossRefGoogle Scholar
  27. 27.
    Albala C, Yanez M, Devoto E et al (1996) Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes 20:1027–1032Google Scholar
  28. 28.
    Aubin JE, Turksen K, Heerche JN M (1993) Osteoblastic cell linkage. In: Noda M (ed) Cellular and molecular biology of bone. Academic Press, New York, pp 1–45Google Scholar
  29. 29.
    Thomas T, Gori F, Khosla S et al (1999) Leptin acts on human marrow stromal cels to enhance differentiation to osteoblast and to inhibit differentiation to adipocytes. Endocrinology 140:1630–1638PubMedCrossRefGoogle Scholar
  30. 30.
    Matkovic V, Jelic T, Wardlaw GM et al (1994) Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from cross-sectional study. J Clin Invest 93:799–808PubMedGoogle Scholar
  31. 31.
    Gulding A, Taylor RW (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456–458CrossRefGoogle Scholar
  32. 32.
    Odabasi E, Ozata M, Turan M et al (2000) Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170–173PubMedCrossRefGoogle Scholar
  33. 33.
    Rauch F, Blum WF, Klein K et al (1998) Does leptin have an effect on bone in adult women? Calcif Tissue Int 63:453–455PubMedCrossRefGoogle Scholar
  34. 34.
    Palmer G, Gabay C (2003) A role for leptin in rheumatic diseases? Ann Rheum Dis 62:913–915PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • M. Wisłowska
    • 1
  • M. Rok
    • 1
  • K. Stępień
    • 2
  • A. Kuklo-Kowalska
    • 2
  1. 1.Department of RheumatologyCentral Clinical HospitalWarsawPoland
  2. 2.Central Laboratory DiagnosticsCentral Clinical HospitalWarsawPoland

Personalised recommendations